News BioNTech reports net loss of €315.1m in Q1 2024 Total revenues for the quarter saw a substantial decrease to €187.6m from €1.27bn in Q1 2023.
Data Insights Q4 2023 update: remote patient monitoring related M&A activity in the pharmaceutical industry
Data Insights Q4 2023 update: electronic medical record (emr) systems related M&A activity in the pharmaceutical industry
Data Insights Q4 2023 update: environmental sustainability related M&A activity in the pharmaceutical industry
News Signal: Novo Nordisk sues more Florida pharmacies in battle against fake semaglutide Isaac Hanson